These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 17111450)
41. CO photodissociation dynamics in cytochrome P450BM3 studied by subpicosecond visible and mid-infrared spectroscopy. Rupenyan A; Commandeur J; Groot ML Biochemistry; 2009 Jul; 48(26):6104-10. PubMed ID: 19492790 [TBL] [Abstract][Full Text] [Related]
42. H2S(g) removal using a modified, low-ph liquid redox sulfur recovery (LRSR) process with electrochemical regeneration of the Fe catalyst couple. Gendel Y; Levi N; Lahav O Environ Sci Technol; 2009 Nov; 43(21):8315-9. PubMed ID: 19924962 [TBL] [Abstract][Full Text] [Related]
43. New members of a class of iron-thiolate-nitrosyl compounds: trinuclear iron-thiolate-nitrosyl complexes containing Fe(3)S(6) core. Hsu IJ; Hsieh CH; Ke SC; Chiang KA; Lee JM; Chen JM; Jang LY; Lee GH; Wang Y; Liaw WF J Am Chem Soc; 2007 Feb; 129(5):1151-9. PubMed ID: 17263396 [TBL] [Abstract][Full Text] [Related]
45. Formation of a sulfur-atom-inserted N-confused porphyrin iron nitrosyl complex by denitrosation and C-S bond cleavage of an S-nitrosothiol. Hung CH; Ching WM; Chang GF; Chuang CH; Chu HW; Lee WZ Inorg Chem; 2007 Dec; 46(26):10941-3. PubMed ID: 18031036 [TBL] [Abstract][Full Text] [Related]
46. Nucleophilic substitution by grignard reagents on sulfur mustards. Converso A; Saaidi PL; Sharpless KB; Finn MG J Org Chem; 2004 Oct; 69(21):7336-9. PubMed ID: 15471488 [TBL] [Abstract][Full Text] [Related]
47. Human P450s involved in drug metabolism and the use of structural modelling for understanding substrate selectivity and binding affinity. Lewis DF; Ito Y Xenobiotica; 2009 Aug; 39(8):625-35. PubMed ID: 19514836 [TBL] [Abstract][Full Text] [Related]
48. Evolved CYP102A1 (P450BM3) variants oxidise a range of non-natural substrates and offer new selectivity options. Whitehouse CJ; Bell SG; Tufton HG; Kenny RJ; Ogilvie LC; Wong LL Chem Commun (Camb); 2008 Feb; (8):966-8. PubMed ID: 18283351 [TBL] [Abstract][Full Text] [Related]
50. Stereospecific oxidation by compound I of cytochrome P450 does not proceed in a concerted synchronous manner. de Visser SP; Ogliaro F; Shaik S Chem Commun (Camb); 2001 Nov; (22):2322-3. PubMed ID: 12240056 [TBL] [Abstract][Full Text] [Related]
51. Modulation of redox potential and alteration in reactivity via the peroxide shunt pathway by mutation of cytochrome P450 around the proximal heme ligand. Matsumura H; Wakatabi M; Omi S; Ohtaki A; Nakamura N; Yohda M; Ohno H Biochemistry; 2008 Apr; 47(16):4834-42. PubMed ID: 18363338 [TBL] [Abstract][Full Text] [Related]
52. Synthesis of sulfur-sulfur bond formation from thioamides promoted by 2,3-dichloro-5,6-dicyanobenzoquinone. Lo WS; Hu WP; Lo HP; Chen CY; Kao CL; Vandavasi JK; Wang JJ Org Lett; 2010 Dec; 12(23):5570-2. PubMed ID: 21067153 [TBL] [Abstract][Full Text] [Related]
54. Microalga Chlorella sorokiniana: a new sulfoxidation biocatalyst. Daligault F; Nugier-Chauvin C; Patin H Org Biomol Chem; 2006 Apr; 4(8):1474-7. PubMed ID: 16604213 [TBL] [Abstract][Full Text] [Related]
55. An introduction to the cytochrome P450s. Estabrook R Mol Aspects Med; 1999; 20(1-2):5-12, 13-137. PubMed ID: 10575647 [No Abstract] [Full Text] [Related]
56. Back to basics; assigning biochemical function in the post-genomic era. Cane DE Chem Biol; 2004 Jun; 11(6):741-3. PubMed ID: 15217605 [No Abstract] [Full Text] [Related]